Dillon & Associates Inc Novartis Ag Transaction History

Dillon & Associates Inc

  • $721 Million
  • Q4 2024

A detailed history of Dillon & Associates Inc transactions in Novartis Ag stock. As of the latest transaction made, Dillon & Associates Inc holds 3,134 shares of NVS stock, worth $330,417. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,134
Previous 3,234 3.09%
Holding current value
$330,417
Previous $372,000 18.28%
% of portfolio
0.04%
Previous 0.05%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025
SELL
$96.78 - $117.18 $9,678 - $11,718
-100 Reduced 3.09%
3,134 $304,000
Q3 2024

Nov 05, 2024
SELL
$106.13 - $120.89 $192,625 - $219,415
-1,815 Reduced 35.95%
3,234 $372,000
Q2 2024

Aug 06, 2024
SELL
$92.57 - $107.37 $25,364 - $29,419
-274 Reduced 5.15%
5,049 $535,000
Q1 2024

Apr 30, 2024
SELL
$95.27 - $108.47 $19,054 - $21,694
-200 Reduced 3.62%
5,323 $516,000
Q4 2023

Feb 08, 2024
SELL
$92.27 - $101.54 $37,092 - $40,819
-402 Reduced 6.78%
5,523 $558,000
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $47,270 - $52,459
-499 Reduced 7.77%
5,925 $604,000
Q2 2023

Aug 08, 2023
SELL
$92.52 - $104.91 $7,401 - $8,392
-80 Reduced 1.23%
6,424 $649,000
Q1 2023

May 02, 2023
SELL
$80.03 - $92.81 $155,658 - $180,515
-1,945 Reduced 23.02%
6,504 $598,000
Q1 2023

May 01, 2023
BUY
$80.03 - $92.81 $6,402 - $7,424
80 Added 0.96%
8,449 $777,000
Q4 2022

Feb 06, 2023
SELL
$75.55 - $92.52 $6,044 - $7,401
-80 Reduced 0.95%
8,369 $762,000
Q1 2021

May 10, 2021
SELL
$83.5 - $98.47 $4,175 - $4,923
-50 Reduced 0.59%
8,449 $718,000
Q4 2020

Feb 12, 2021
SELL
$78.07 - $94.43 $14,833 - $17,941
-190 Reduced 2.19%
8,499 $799,000
Q1 2020

May 07, 2020
SELL
$70.67 - $99.01 $17,667 - $24,752
-250 Reduced 2.8%
8,689 $712,000
Q4 2019

Feb 03, 2020
BUY
$84.35 - $95.37 $16,026 - $18,120
190 Added 2.17%
8,939 $849,000
Q3 2019

Oct 25, 2019
SELL
$85.54 - $94.26 $1,112 - $1,225
-13 Reduced 0.15%
8,749 $761,000
Q2 2019

Jul 22, 2019
BUY
$75.4 - $92.8 $1,885 - $2,320
25 Added 0.29%
8,762 $797,000
Q1 2019

May 07, 2019
SELL
$75.32 - $86.15 $26,361 - $30,152
-350 Reduced 3.85%
8,737 $839,000
Q3 2018

Nov 14, 2018
SELL
$66.94 - $77.43 $1,673 - $1,935
-25 Reduced 0.27%
9,087 $781,000
Q2 2018

Aug 08, 2018
SELL
$64.91 - $73.36 $87,628 - $99,036
-1,350 Reduced 12.9%
9,112 $693,000
Q1 2018

May 08, 2018
SELL
$70.39 - $84.15 $17,597 - $21,037
-250 Reduced 2.33%
10,462 $847,000
Q3 2017

Nov 13, 2017
SELL
$74.14 - $77.27 $1,853 - $1,931
-25 Reduced 0.23%
10,712 $921,000
Q2 2017

Aug 09, 2017
BUY
N/A
10,737
10,737 $891,000

Others Institutions Holding NVS

# of Institutions
1,462
Shares Held
132M
Call Options Held
1.33M
Put Options Held
1.54M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $227B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Dillon & Associates Inc Portfolio

Follow Dillon & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email